OpenExamsFREE PRACTICE — ANY EXAM

Texas Pharmacist — Requirements & Free Practice

US-TX · License preparation

300 free questions · Answer explanations · No signup required

Choose what to practice

Start with an exam below. Your examination requirements depend on your application pathway. View licensing requirements

Combined practice

Choose an exam or combined practice to begin.

Licenses, application pathways and examination requirements

Each license and applicant pathway has its own requirements and exemptions. Choosing practice questions does not determine your eligibility.

Pharmacist License

License to practice pharmacy in Texas issued by the Texas State Board of Pharmacy under Occupations Code Chapter 558.

Licensing authority: Texas State Board of Pharmacy · Application information

Licensure by examination (including NAPLEX score transfer)

All of the following:

Age
At least 18 years of age (22 TAC §283.3).
Criminal History
Fingerprint-based criminal history record check (22 TAC §283.7(1)(B)).
Education
A professional degree (B.S. in Pharmacy or Pharm.D.) from a Board-approved ACPE-accredited college of pharmacy, or, for a graduate of a foreign college of pharmacy, full certification from the Foreign Pharmacy Graduate Equivalency Commission (FPGEC) (22 TAC §283.3; Board foreign pharmacy graduate page).
Internship
Completion of the minimum internship hours (1,740) required by the Board (Occupations Code §558.051(a)(2)(B); 22 TAC §283.4; Board exam page).
Prior Discipline
No pharmacist license granted by another state restricted, suspended, revoked or surrendered (Occupations Code §558.051(a)(2)(E)).
Retakes
Each examination may be retaken four additional times; further retakes require Board-recommended course work (22 TAC §283.11(a)).
Score Transfer
An applicant may transfer NAPLEX scores from another state through the NABP NAPLEX Score Transfer Program and pay the score transfer fee (22 TAC §283.7(7), §283.9(a)(3)).
Score Validity
A passing grade on an examination may be used for licensure for two years from the date of passing (22 TAC §283.7(6)).
Reactivation of an inactive pharmacist license
No examination is required for this applicant pathway.
Application
Apply for active status on a Board form (22 TAC §295.9(c)(1)(A)).
Continuing Education
30 hours of approved continuing education, including at least one contact hour on Texas pharmacy laws or rules (22 TAC §295.9(c)(1)(B)).
Emergency
In an emergency the executive director may allow reactivation of a license inactive no more than two years before the continuing education is completed (22 TAC §295.9(c)(3)).
Fee
Renewal fee or amended license fee depending on timing (22 TAC §295.9(c)(2)).
Expedited licensure by reciprocity for military service members, veterans and spouses
Texas Pharmacy Jurisprudence Examination (practice unavailable)
Applications
Complete the Texas and NABP applications for reciprocity and the fingerprint-based criminal history check (22 TAC §283.12(c)(2)-(3)).
Education
Meets the educational and age requirements of 22 TAC §283.3 (22 TAC §283.12(c)(1)).
Fees
Exempt from the Board application and examination fees in 22 TAC §283.9(a)(2)(A) and (b) (22 TAC §283.12(c)(6)).
Licensure
Holds a current license similar in scope of practice issued by another state and in good standing, or held a Texas pharmacist license within the five years preceding the application; proof of initial licensing by examination and of no restricted license (22 TAC §283.12(c), (c)(4)).
Military Status
Military service member, military veteran or military spouse (22 TAC §283.12(a), (c)).
Military alternative licensing procedure for an applicant whose Texas pharmacist license expired within the preceding five years
No examination is required for this applicant pathway.
Continuing Education
15, 30 or 45 contact hours of approved continuing education depending on how long the license has been expired (22 TAC §283.12(b)(3)(D)).
Fee
Pay the renewal fee in 22 TAC §295.5; exempt from the late fees in 22 TAC §295.7(3) (22 TAC §283.12(b)(3)(C)).
Military Status
Military service member, military veteran or military spouse with documentation of eligibility (22 TAC §283.12(b)(3)(B)).
Prior License
Texas pharmacist license expired within the five years preceding the application (22 TAC §283.12(b)(3)).

Official no-examination sources

Effective from 2026-03-01.

Licensure by reciprocity (license transfer)

All of the following:

Criminal History
Fingerprint-based criminal history record check (22 TAC §283.8(a)(2)).
Education
A professional degree from a college of pharmacy, or FPGEC full certification for a foreign pharmacy graduate (22 TAC §283.3, §283.8(c)(1)).
Licensure
Proof of current or initial licensing by examination in another state, and no license granted by any state suspended, revoked, canceled, surrendered or otherwise restricted (Occupations Code §558.101(a)(3); 22 TAC §283.8(a)(4)).
Nabp Application
Complete the Texas and NABP applications for reciprocity (license transfer) (22 TAC §283.8(a)(3)).
National Examination
An applicant originally licensed after January 1, 1978 shows proof of passing the NAPLEX or an equivalent examination based on criteria no less stringent than those in force in Texas; an equivalent examination other than the NAPLEX is accepted on those terms (22 TAC §283.8(b), (c)(2)). The Board page lists only the MPJE for Texas and proof of licensing by examination.
Reciprocal State
The state of current or initial licensure must grant reciprocal licensing to pharmacists licensed by examination in Texas under like circumstances (Occupations Code §558.101(b); 22 TAC §283.8(d)).
Score Validity
The Texas Pharmacy Jurisprudence Examination passing grade may be used for licensure by reciprocity for two years (22 TAC §283.8(a)(5)).
Relicensure of a Texas license expired one year or more but less than 10 years, applicant not practicing pharmacy
Texas Pharmacy Jurisprudence Examination (practice unavailable)
Completion Window
All requirements must be completed within two years of passing the Texas Pharmacy Jurisprudence Examination (22 TAC §283.10(g)(4)).
Continuing Education And Internship
Approved continuing education of 15 to 45 contact hours and, for a license expired more than four years, 500 to 1,500 hours of Board-approved internship, according to the schedule in 22 TAC §283.10(g)(1)(D).
Fee
Pay the examination fee in 22 TAC §283.9 (22 TAC §283.10(g)(1)(C)).
Other Board Examination
Occupations Code §559.005(c)(3) also allows the Board to require "any other examination required by the board"; the Board rule names no other examination for this route.
Prior License
Was licensed as a pharmacist in Texas and the license has been expired for less than 10 years (22 TAC §283.10(g)(1)).
Relicensure of a Texas license expired one year or more, applicant practicing pharmacy in another state
Texas Pharmacy Jurisprudence Examination (practice unavailable)
Continuing Education
At least 30 contact hours of approved continuing education during the preceding two license years (22 TAC §283.10(f)(2)(C)).
Fee
Pay the examination fee in 22 TAC §283.9 (22 TAC §283.10(f)(4)).
No Restriction
No license granted by any other state suspended, revoked, canceled, surrendered or otherwise restricted (22 TAC §283.10(e)).
Prior License
Was licensed as a pharmacist in Texas, moved to another state, is licensed in good standing there and has been continuously employed as a pharmacist there for the two years preceding the application (Occupations Code §559.005(b); 22 TAC §283.10(f)).
Relicensure by reexamination of a Texas license expired one year or more (required when expired 10 years or more)

All of the following:

Original License Requirements
Comply with the requirements and procedures for an original license under 22 TAC §283.7, including internship requirements of 22 TAC §283.4 (22 TAC §283.10(g)(5); Occupations Code §559.003(d)).
Prior License
Held a Texas pharmacist license expired one year or more; an applicant whose license has been expired 10 years or more must use this route (22 TAC §283.10(d), (g)(5)).
License renewal, including late renewal of a license expired less than one year
No examination is required for this applicant pathway.
Late Renewal
A license expired 90 days or less is renewed for one and one-half times the renewal fee; expired more than 90 days but less than one year, for two times the renewal fee (Occupations Code §559.003(b)-(c); 22 TAC §295.7(3)).
Military
A military service member is entitled to two additional years to complete renewal requirements (22 TAC §283.12(d)).
Renewal
Pay the renewal fee, comply with continuing education requirements and file a completed renewal application before the expiration date (Occupations Code §559.003(a); 22 TAC §295.7).

North American Pharmacist Licensure Examination

Provider
National Association of Boards of Pharmacy
Format
Computerized fixed form
Exam questions
225 questions
Time limit
6 hours
Passing score
Pass or Fail
Examination outline
  • Foundational Knowledge for Pharmacy Practice (25%)
    • Pharmaceutical science principles and concepts
    • Pharmaceutical science principles and concepts: Pharmacology
    • Pharmaceutical science principles and concepts: Pharmacokinetics, pharmacodynamics, or pharmacogenomics
    • Pharmaceutical science principles and concepts: Pharmaceutics
    • Pharmaceutical compounding
    • Pharmaceutical compounding: Nonsterile preparations
    • Pharmaceutical compounding: Sterile preparations
    • Pharmaceutical calculations
    • Pharmaceutical calculations: Patient parameters or laboratory measures
    • Pharmaceutical calculations: Quantities of drugs to be dispensed or administered
    • Pharmaceutical calculations: Rates of administration
    • Pharmaceutical calculations: Dose conversions
    • Pharmaceutical calculations: Drug concentrations, ratio strengths, osmolarity, or osmolality
    • Pharmaceutical calculations: Quantities of drugs or ingredients to be compounded
    • Pharmaceutical calculations: Nutritional needs and the content of nutrient sources
    • Pharmaceutical calculations: Biostatistical, epidemiological, or pharmacoeconomic measures
    • Pharmaceutical calculations: Pharmacokinetic parameters
    • Drug development processes (eg, clinical trial phases, emergency use authorizations)
    • Research design principles and biostatistics (eg, blinding, randomization, biases, statistical tests and outcomes, ethics)
    • Retrieval, assessment, and interpretation of primary, secondary, and tertiary resources
  • Medication Use Process (Prescribing, Transcribing and Documenting, Dispensing, Administering, and Monitoring) (25%)
    • Prescriptions and medication order interpretation
    • Prescriptions and medication order interpretation: Drug names and therapeutic classes
    • Prescriptions and medication order interpretation: Indications, usage, and dosing regimens
    • Prescriptions and medication order interpretation: Available dosage forms
    • Prescriptions and medication order interpretation: Prescription regulations (eg, boxed warnings, risk evaluation and mitigation strategies)
    • Prescriptions and medication order interpretation: Safety and effectiveness (eg, laboratory parameters, vital signs)
    • Therapeutic substitutions (eg, formulary restrictions, therapeutic alternatives, shortages, biosimilars)
    • Immunization services and documentation
    • Immunization services and documentation: Indications and scheduling
    • Immunization services and documentation: Contraindications and precautions
    • Immunization services and documentation: Storage and handling
    • Immunization services and documentation: Administration (eg, techniques, preparation, routes)
    • Immunization services and documentation: Adverse reactions
    • Medication handling, storage, stability, and disposal (eg, hazardous and nonhazardous drugs, controlled substances, parenteral medications, sharps handling, temperature control)
  • Person-Centered Assessment and Treatment Planning (40%)
    • Medication history, allergy history, and reconciliation
    • Health histories, screenings, and assessments
    • Patient health conditions, including special populations and medication-related factors
    • Patient health conditions, including special populations and medication-related factors: Signs, symptoms, and findings of medical conditions, etiology of diseases, or pathophysiology
    • Patient health conditions, including special populations and medication-related factors: Appropriateness of therapy (eg, medications, immunizations, non-drug therapy, dosing, contraindications, warnings, evidence-based decision making)
    • Patient health conditions, including special populations and medication-related factors: Interactions (eg, drug-drug, drug-condition, drug-food, drug-allergy, drug-laboratory)
    • Patient health conditions, including special populations and medication-related factors: Errors and omissions (eg, dosing, duplication, additional therapy needed, unnecessary therapy)
    • Patient health conditions, including special populations and medication-related factors: Adverse drug reactions
    • Patient health conditions, including special populations and medication-related factors: Toxicologic exposures and overdoses
    • Patient health conditions, including special populations and medication-related factors: Adherence
    • Therapeutic monitoring, plan development, evaluation, and modifications
    • Therapeutic monitoring, plan development, evaluation, and modifications: Therapeutic goals, clinical endpoints, and follow-up
    • Therapeutic monitoring, plan development, evaluation, and modifications: Safety
    • Therapeutic monitoring, plan development, evaluation, and modifications: Effectiveness
    • Patient education
    • Patient education: Lifestyle modifications and health maintenance
    • Patient education: Medication use, storage, and disposal
    • Patient education: Disease state management
    • Over-the-counter medications and dietary supplements
    • Devices to administer medications and self-monitoring tests
  • Professional Practice (5%)
    • Adverse drug event reporting and medication error reporting (eg, MedWatch, VAERS)
    • Public health initiatives and risk-prevention programs (eg, tobacco and nicotine cessation, antimicrobial stewardship, health screenings, opioid stewardship)
    • Social determinants and drivers of health
    • Ethical considerations (eg, informed consent, ethical principles, professional conduct and responsibility, patient confidentiality)
  • Pharmacy Management and Leadership (5%)
    • Pharmacy operations (eg, operational planning, risk management, regulations and regulatory bodies, technology applications and informatics, error-prevention strategies, medication safety)
    • Inventory and supply management (eg, drug recalls, drug shortages)
    • Quality improvement activities (eg, medication use evaluation, root-cause analysis, continuous quality improvement)
    • Mentorship and preceptorship (eg, providing and receiving feedback, delegation of work activities, preceptor roles)
Examination sources

Texas Pharmacy Jurisprudence Examination

Provider
National Association of Boards of Pharmacy (Texas version of the MPJE)
Format
Multiple-choice
Exam questions
120
Time limit
2.5 hours
Passing score
75
Examination outline
  • Licensure/Personnel (22%)
    • Responsibilities of the pharmacist and non-pharmacist personnel
    • Qualifications, scope of duties, limitations, and restrictions of duties, or conditions to practice for pharmacists-in-charge (or equivalent) and pharmacists
    • Qualifications, scope of duties, limitations, and restrictions of duties, or conditions to practice for non-pharmacist personnel
    • Licensures, registrations, and certifications for pharmacists or non-pharmacist personnel
    • Qualifications, examinations, internships, maintaining pharmacist competency, and renewals of licensures, registrations, or certifications
    • Classifications and processes of disciplinary actions
    • Reporting to and participating in programs addressing the inability to practice with reasonable skill and safety
  • Pharmacist Practice (33%)
    • Requirements for issuing prescriptions/drug orders
    • Requirements for drug uses, limitations, or restrictions
    • Scope of authority, scope of practice, limitations or restrictions of practice, and valid registration of practitioners who are authorized to prescribe, dispense, or administer drugs
    • Requirements for issuing non-controlled prescriptions/drug orders
    • Requirements for issuing controlled prescriptions/drug orders
    • Authority limitations of practitioners’ ability to authorize refills
    • Conditions under which the pharmacist or non-pharmacist personnel participates in the administration of drugs in the management of patients’ therapy
    • Requirements regarding counseling
    • Counseling or offering to counsel
    • Documenting counseling or documenting offering to counsel
    • Returning or reusing drugs
    • Regulations and agencies regarding pharmacy practice
    • Requirements for promoting quality and safety of public health
    • Protecting patient and health record confidentiality
  • Dispensing Requirements (24%)
    • Responsibilities for determining whether prescriptions/drug orders are issued for a legitimate medical purpose, and within all applicable restrictions
    • Transferring prescription/drug order information between pharmacies by authorized personnel
    • Prospective drug utilization reviews
    • Requirements for reporting to PMP and accessing PMP data
    • Exceptions to dispensing or refilling prescriptions/drug orders
    • Labeling of dispensed drugs
    • Packaging of dispensed drugs
    • Drug product conditions prohibiting dispensing
    • Requirements for the distribution and/or dispensing of non-prescription pharmaceutical products, including controlled substances and hazardous drugs
    • Dispensing or administration
    • Labeling of non-prescription drugs and devices
    • Packaging and repackaging of non-prescription drugs and behind-the-counter products
    • Dispensing-restricted, non-prescription drugs
  • Pharmacy Operations (21%)
    • Ordering, acquisition, and distribution of drugs, including maintenance and content of such records
    • Ordering and acquisition, including the maintenance and content of such records
    • Distribution, including the maintenance and content of such records
    • Recordkeeping in compliance with legal requirements, including content, inventory, maintenance, storage, handling, and reporting
    • Non-dispensing requirements for operations of pharmacies or practice settings
    • Possession, storage, and handling of non-hazardous drugs
    • Training, possession, handling, storage, and disposal of hazardous drugs
    • Allowing non-pharmacist personnel access to drugs
    • Requirements for conducting controlled substance inventories
    • Delivery of drugs
    • Conditions for permitted or mandated product selection
    • Compounding sterile, nonsterile, hazardous, and non-hazardous preparations
    • Centralized prescription processing or central-fill pharmacy dispensing
    • Requirements for the registration, licensure, certification, or permitting of a practice setting or business entity
    • Requirements for registration, license, certification, or permitting of a practice setting
    • Requirements for the renewal or reinstatement of a license, registration, certificate, or permit of a practice setting
    • Requirements for an inspection of a licensed, registered, certified, or permitted practice setting
    • Classifications and processes of disciplinary actions that may be taken against a registered, licensed, certified, or permitted practice setting
Examination sources